Eptifibatide recalls

The FDA has published 6 recalls involving Eptifibatide since 2016. The latest was reported on 4 Mar 2026. Most were for potency & assay. Akorn has the most recalls in this group. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.

Total recalls6since 2016
Last 12 months1reported
Class I00% of total
Ongoing2latest 4 Mar 2026

Recalls per month, last 24 months

click a bar for that month

Severity split

Class I 0 0%Class II 1 17%Class III 5 83%

Why eptifibatide is recalled

By year

Ongoing eptifibatide recalls

2 active
ReportedClassRecallCompanyReasonWhere
DrugCLASS IIIEptifibatide Injection, 75 mg/ vial recalledEptifibatideSlate Run PharmaceuticalsOtherNationwide
DrugCLASS IIIEptifibatide injection 20mg/ (2mg/mL) Single-Dose Vial recalledEptifibatideEugia USPotency & AssayNationwide

All eptifibatide recalls, newest first

6 total

Should you stop taking Eptifibatide?

Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.